World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
28084
World Ranking
2030
National Ranking
76

Overview

Massimo Puoti is affiliated with the University of Milano-Bicocca in Italy. Their research predominantly spans the field of Medicine, with a particular focus on Infectious Diseases, Epidemiology, and Hepatology. Subfields they contribute to include Neurology and Virology, reflecting an interdisciplinary approach to medical research.

Their work covers key topics such as Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, and various aspects of COVID-19 clinical research. They have also addressed HIV/AIDS drug development and treatment.

Frequent coauthors collaborating with Massimo Puoti include:

  • Antonella d'Arminio Monforte
  • Marco Merli
  • Roberto Rossotti
  • Carlo Federico Perno
  • Annalisa Saracino

The venues in which Massimo Puoti publishes often include journals specializing in hepatology, infectious diseases, and antimicrobial chemotherapy, such as:

  • Journal of Hepatology
  • Digestive and Liver Disease
  • Liver International
  • Journal of Antimicrobial Chemotherapy
  • International Journal of Infectious Diseases

Representative recent scientific papers authored or coauthored by Massimo Puoti are:

  • EASL recommendations on treatment of hepatitis C: Final update of the series (2020), Journal of Hepatology
  • 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 (2020), HIV Medicine
  • Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report (2020), Brain Behavior and Immunity
  • Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy (2021), Nature Communications
  • Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis (2020), Journal of Infection

Best Publications

  • EASL Recommendations on Treatment of Hepatitis C

    Jean-Michel Pawlotsky;Alessio Aghemo;Geoffrey Dusheiko;Xavier Forns

  • Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

    Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier

  • Statements from the Taormina expert meeting on occult hepatitis B virus infection.

    Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia

  • EASL recommendations on treatment of hepatitis C: Final update of the series ☆

    Jean-Michel Pawlotsky;Francesco Negro;Alessio Aghemo;Marina Berenguer

  • A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

    Francesco Donato;Paolo Boffetta;Massimo Puoti

  • A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.

    Markus Cornberg;Homie A. Razavi;Alfredo Alberti;Enos Bernasconi

  • Update of the statements on biology and clinical impact of occult hepatitis B virus infection

    Giovanni Raimondo;Stephen Locarnini;Teresa Pollicino;Massimo Levrero

  • Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Stefan Zeuzem;Graham R Foster;Stanley Wang;Armen Asatryan

  • Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

    Vincent Soriano;Massimo Puoti;Mark Sulkowski;Antonietta Cargnel

  • Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

    Vincent Soriano;Mark Sulkowski;Colm Bergin;Angelos Hatzakis

  • Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Unknown

  • Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences.

    Luisa Imberti;Alessandra Sottini;Alessandra Bettinardi;Massimo Puoti

  • Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome.

    Puoti M;Bruno R;Soriano;Donato F

  • European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.

    JK Rockstroh;S Bhagani;Y Benhamou;R Bruno

  • Mortality for liver disease in patients with HIV infection: a cohort study.

    Massimo Puoti;Angiola Spinetti;Annibale Ghezzi;Francesco Donato

  • Natural history of chronic hepatitis B in co-infected patients

    Massimo Puoti;Carlo Torti;Raffaele Bruno;Gaetano Filice

  • Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

    Andrea De Luca;Roberto Bugarini;Alessandro Cozzi Lepri;Massimo Puoti

  • Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.

    Luz Martín-Carbonero;Yves Benhamou;Massimo Puoti;Juan Berenguer

  • Liver Fibrosis Progression Is Related to CD4 Cell Depletion in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus

    Massimo Puoti;Maurizio Bonacini;Angiola Spinetti;Valeria Putzolu

  • Care of patients with hepatitis C and HIV co-infection.

    Vincent Soriano;Massimo Puoti;Mark Sulkowski;Stefan Mauss

  • Prophylaxis and treatment of hepatitis B in immunocompromised patients

    A Marzano;E Angelucci;P Andreone;M Brunetto

Frequent Co-Authors

Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Giampiero Carosi
Giampiero Carosi University of Brescia
Antonio Craxì
Antonio Craxì University of Palermo
Carlo Federico Perno
Carlo Federico Perno University of Milan
Andrea Gori
Andrea Gori University of Milan
Andrea De Luca
Andrea De Luca University of Siena
Pietro Lampertico
Pietro Lampertico University of Milan
Andrea Antinori
Andrea Antinori Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Alessandro Cozzi-Lepri
Alessandro Cozzi-Lepri University College London
Giuliano Rizzardini
Giuliano Rizzardini ASST Fatebenefratelli Sacco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to diverse healthcare careers, many of which can be further enhanced through specialized nursing and practitioner programs. For students interested in clinical roles, exploring easiest lpn programs to get into offers a practical starting point. These programs often provide flexible options for gaining foundational nursing skills.

For those aiming to advance their responsibilities, easy nurse practitioner programs to get into provide opportunities to obtain advanced certifications that complement an immunology background, facilitating roles in patient care and disease management.

Specializing further into mental health can also be a natural progression. Programs highlighted among the top online pmhnp programs ensure excellent clinical experiences, crucial for those looking to integrate immunological research with psychiatric care.

Affordability remains a key consideration for many students. Thankfully, options like the affordable pmhnp programs make advanced psychiatric nursing education accessible without compromising quality, supporting a range of career trajectories linked to immunology.

Best Scientists Citing Massimo Puoti

Trending Scientists

Recently Published Articles